Top Clinical Trials companies in Canada by EBITDA

This ranking features the top 30 Clinical Trials companies in Canada ranked by EBITDA, totaling a EBITDA of USD 927.50 M, for July 04, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue Revenue Year-on-Year (YoY) growth Operating Income EBIT Free Cash Flow Dividend Yield Free Cash Flow Yield Total Assets Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

Frequently Asked Questions

Which Clinical Trials company in Canada has the highest EBITDA ?

The Clinical Trials company in Canada with the highest EBITDA is Bausch Health Companies Inc. (Toronto Stock Exchange: BHC.TO) at USD 1.55 B.

Which Clinical Trials company in Canada has the lowest EBITDA ?

The Clinical Trials company in Canada with the lowest EBITDA is Repare Therapeutics Inc. (NasdaqGS: RPTX) at None.

What are the top 10 Clinical Trials companies in Canada by EBITDA ?

The top 10 Clinical Trials companies in Canada by EBITDA are Bausch Health Companies Inc., Knight Therapeutics Inc., Aurora Cannabis Inc., Aurinia Pharmaceuticals Inc., Medexus Pharmaceuticals Inc., HLS Therapeutics Inc., Cipher Pharmaceuticals Inc., Theratechnologies Inc., Medicure Inc. and Sunshine Biopharma, Inc..

What are the bottom 10 Clinical Trials companies in Canada by EBITDA ?

The bottom 10 Clinical Trials companies in Canada by EBITDA are Repare Therapeutics Inc., Zymeworks Inc., InMed Pharmaceuticals Inc., Ondine Biomedical Inc., Aptose Biosciences Inc., ESSA Pharma Inc., Milestone Pharmaceuticals Inc., Xenon Pharmaceuticals Inc., AbCellera Biologics Inc. and Mind Medicine (MindMed) Inc..